Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol
Year: 2012
Type: article
Source: Blood
Authors: Paul G. Richardson, Angela Smith, Nancy A. Kernan, Stephan A. Grupp, Sally Arai, Brandon M. Triplett, Paul R. Haut, Kawah Chan, Heather J. Symons, Biljana N. Horn, Alfred P. Gillio, Michael Boyer, Amrita Krishnan, Leslie E. Lehmann, Paul L. Martin, Shin Mineishi, Tsiporah B. Shore, Tiffany Simms-Waldrip, Joseph H. Antin, Alison L. Hannah, Robin Hume, Elena Tudone, Carin Heringa, Robert J. Soiffer, Defibrotide Study Group
Institutions: Dana-Farber Cancer Institute, University of Minnesota, Memorial Sloan Kettering Cancer Center, Children's Hospital of Philadelphia, Stanford Medicine, Stanford University, St. Jude Children's Research Hospital, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Methodist Children’s Hospital, Johns Hopkins University, University of California, San Francisco, UCSF Benioff Children's Hospital, Hackensack University Medical Center, Primary Children's Hospital, City Of Hope National Medical Center, City of Hope, Duke University, University of Alabama at Birmingham, NewYork–Presbyterian Hospital, The University of Texas Southwestern Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4231494599